Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Grootendorst

Showing results (31-40 of 72) with videos related to

Pageof 8
Sort By:
Health Economics|August 30, 2005
Estimating the price elasticity of expenditure for prescription drugs in the presence of non-linear price schedules: an illustration from Quebec, CanadaPaul Contoyannis, Jeremiah Hurley, Paul Grootendorst, et al.
Pharmacoeconomics - Open|February 15, 2018
Differences in Incremental Cost-Effectiveness Ratios for Common Versus Rare Conditions: A Case from OncologyKavisha Jayasundara, Murray Krahn, Muhammad Mamdani, et al.
BMC Women'S Health|September 13, 2007
Becoming the best mom that I can: women's experiences of managing depression during pregnancy--a qualitative studyHeather A Bennett, Heather S Boon, Sarah E Romans, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 17, 2022
Modeling Tiered Pricing Frameworks: A Simulation ApproachJavad Moradpour, Wei Zhang, Paul Grootendorst, et al.
Drug and Alcohol Dependence|March 9, 2024
Association between non-medical cannabis legalization and alcohol sales: Quasi-experimental evidence from CanadaShweta Mital, Lisa Bishop, Shawn Bugden, et al.
Inquiry : a Journal of Medical Care Organization, Provision and Financing|May 3, 2015
The opportunity cost of capital: development of new pharmaceuticalsAyman Chit, Ahmad Chit, Manny Papadimitropoulos, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|June 17, 2006
Can current electronic systems meet drug safety and effectiveness requirements?Anne Holbrook, Paul Grootendorst, Don Willison, et al.
Cannabis and Cannabinoid Research|January 31, 2023
Changes in Medical Cannabis Use After Recreational Cannabis Legalization in CanadaHai V Nguyen, Paul Grootendorst, Shweta Mital, et al.
The Canadian Journal of Clinical Pharmacology = Journal Canadien De Pharmacologie Clinique|July 25, 2003
Coding accuracy of administrative drug claims in the Ontario Drug Benefit databaseAdrian R Levy, Bernie J O'Brien, Connie Sellors, et al.
Health Policy (Amsterdam, Netherlands)|April 12, 2024
The impact of changing the reference countries on the list prices for patented medicines in Canada: A policy analysisWei Zhang, Daphne P Guh, Paul Grootendorst, et al.
Pageof 8

Showing results (31-40 of 72) with videos related to

Sort By:
Pageof 8
Health Economics|August 30, 2005
Estimating the price elasticity of expenditure for prescription drugs in the presence of non-linear price schedules: an illustration from Quebec, CanadaPaul Contoyannis, Jeremiah Hurley, Paul Grootendorst, et al.
Pharmacoeconomics - Open|February 15, 2018
Differences in Incremental Cost-Effectiveness Ratios for Common Versus Rare Conditions: A Case from OncologyKavisha Jayasundara, Murray Krahn, Muhammad Mamdani, et al.
BMC Women'S Health|September 13, 2007
Becoming the best mom that I can: women's experiences of managing depression during pregnancy--a qualitative studyHeather A Bennett, Heather S Boon, Sarah E Romans, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 17, 2022
Modeling Tiered Pricing Frameworks: A Simulation ApproachJavad Moradpour, Wei Zhang, Paul Grootendorst, et al.
Drug and Alcohol Dependence|March 9, 2024
Association between non-medical cannabis legalization and alcohol sales: Quasi-experimental evidence from CanadaShweta Mital, Lisa Bishop, Shawn Bugden, et al.
Inquiry : a Journal of Medical Care Organization, Provision and Financing|May 3, 2015
The opportunity cost of capital: development of new pharmaceuticalsAyman Chit, Ahmad Chit, Manny Papadimitropoulos, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|June 17, 2006
Can current electronic systems meet drug safety and effectiveness requirements?Anne Holbrook, Paul Grootendorst, Don Willison, et al.
Cannabis and Cannabinoid Research|January 31, 2023
Changes in Medical Cannabis Use After Recreational Cannabis Legalization in CanadaHai V Nguyen, Paul Grootendorst, Shweta Mital, et al.
The Canadian Journal of Clinical Pharmacology = Journal Canadien De Pharmacologie Clinique|July 25, 2003
Coding accuracy of administrative drug claims in the Ontario Drug Benefit databaseAdrian R Levy, Bernie J O'Brien, Connie Sellors, et al.
Health Policy (Amsterdam, Netherlands)|April 12, 2024
The impact of changing the reference countries on the list prices for patented medicines in Canada: A policy analysisWei Zhang, Daphne P Guh, Paul Grootendorst, et al.
Pageof 8